According to Coherus BioSciences
's latest financial reports the company has a price-to-book ratio of 0.449334.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | -1.95 | 1.78% |
2023-12-31 | -1.92 | -57.23% |
2022-12-31 | -4.48 | -135.75% |
2021-12-31 | 12.5 | 181.38% |
2020-12-31 | 4.46 | -62.99% |
2019-12-31 | 12.0 | -175.18% |
2018-12-31 | -16.0 | -194.65% |
2017-12-31 | 16.9 | -73.35% |
2016-12-31 | 63.5 | -149.12% |
2015-12-31 | -129 | -1689.68% |
2014-12-31 | 8.13 | |
2013-12-31 | N/A |